Skip to main content
Figure 4 | BMC Infectious Diseases

Figure 4

From: High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis

Figure 4

Correlation between sCD40L and MMP-9 levels with spleen size or parasite load during VL treatment. (A) Correlation between MMP-9 and spleen size before treatment (n = 30; r = −0.38; p < 0.05). (B) Correlation between sCD40L and spleen size at D15 of treatment (n = 33; r = −0.36; p < 0.05). (C) Correlation between sCD40L with parasite load at D0, D30, D60 (n = 41; r = −0.34; p < 0.05). (D) MMP-9 with parasite load at D0, D30, D60 (n = 39; r = −0.50; p < 0.001). Spearman correlation test.

Back to article page